文献速递前列腺癌

复发性前列腺癌的复发模式、检出率及18-F Fluciclovine PET/CT对治疗决策的影响

Patterns of Recurrence, Detection Rates, and Impact of 18-F Fluciclovine PET/CT on the Management of Men With Recurrent Prostate Cancer.
PubMed 文献 · Urology · 2021-01-29

本研究为单中心回顾性研究,纳入103例根治性治疗后生化复发的前列腺癌患者,评估FACBC PET/CT的检出率及对放疗推荐的影响。

要点

  • FACBC PET/CT检出率随PSA升高而增加,PSA>2 ng/mL时达95.2%。
  • 大多数复发灶位于盆腔外,PSA<1 ng/mL时45.5%已存在前列腺外或盆腔外复发。
  • FACBC PET/CT改变了44.1%根治性前列腺切除术后复发患者的放疗推荐。

核心结论

  • FACBC PET/CT对复发性前列腺癌的检出率随PSA水平升高而增加,且多数复发位于盆腔外。
  • FACBC PET/CT结果改变了根治性前列腺切除术后复发患者的放疗管理决策,支持其用于定位复发部位。

研究设计与样本

  • 单中心回顾性研究,纳入103例接受FACBC PET/CT检查的 definitive 治疗后PSA升高的前列腺癌患者。
  • 比较不同PSA水平和解剖部位的检出率,并对比基于常规影像与FACBC PET/CT的放疗推荐。

主要发现

  • 74.8%(77例)患者发现与前列腺癌复发一致的病灶。
  • 最常见复发部位为盆腔外(37例),PSA<1 ng/mL组中45.5%存在前列腺外或盆腔外复发。
  • 根治性前列腺切除术后复发患者中,44.1%(15/34)因FACBC PET/CT结果改变了放疗计划。

临床怎么用

  • 对于根治性治疗后生化复发的前列腺癌患者,可考虑使用FACBC PET/CT定位复发灶,尤其在PSA升高时。
  • FACBC PET/CT结果可能改变放疗靶区或方案,尤其对根治性前列腺切除术后复发者。

局限性

  • 单中心回顾性设计,样本量有限(103例)。
  • 未报告常规影像与FACBC PET/CT的头对头比较细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the characteristics of FACBC PET/CT in detecting recurrent prostate cancer after radiation or prostatectomy. The secondary aim was to determine the impact of FACBC PET/CT on radiation treatment recommendations in men with biochemical recurrence postprostatectomy. METHODS: This is a single center retrospective study of men who underwent an FACBC PET/CT for rising PSA after definitive prostate cancer therapy. Detection rates in men with recurrence following any definitive treatment were compared at different PSA levels and anatomical sites. Radiotherapy treatment recommendations for patients postprostatectomy based on conventional imaging findings were compared to recommendations based on FACBC PET/CT findings. RESULTS: A total of 103 men underwent imaging with FACBC PET/CT. 74.8% (77) had lesions consistent with sites of prostate cancer recurrence. At PSA thresholds of <1, 1-2, and >2 ng/mL lesions were detected in 35.5%, 63.6%, and 95.2% of patients respectively (P <.001). The most common site of recurrence was outside of the pelvis (37). Detection of extraprostatic or extrapelvic recurrence was observed in 45.5% of men in the PSA tertile <1ng/mL. FACBC PET/CT results led to changes to the recommended radiotherapy treatment plan in 44.1% (15/34) of men with recurrence following radical prostatectomy. CONCLUSION: FACBC PET/CT demonstrated increased detection of recurrent prostate cancer with increasing PSA levels. Most recurrences were found outside the pelvis. Results of FACBC PET/CT changed radiotherapy management decisions in men treated with prostatectomy, supporting its use in localizing sites of disease recurrence in men with prostate cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Michael J, Khandani AH, Basak R, et al. Patterns of Recurrence, Detection Rates, and Impact of 18-F Fluciclovine PET/CT on the Management of Men With Recurrent Prostate Cancer. Urology. 2021. PMID: 33516829. doi:10.1016/j.urology.2021.01.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。